Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.79 | N/A |
| PEG Ratio (TTM) | 0.94 | N/A |
| P/S Ratio (TTM) | 1.53 | N/A |
| P/B Ratio (TTM) | 1.54 | N/A |
| P/FCF Ratio (TTM) | -4.20 | N/A |
| Price to 5YR AVG Earnings Ratio | 31.85 | N/A |
| Price to 5YR AVG FCF Ratio | 16.72 | N/A |
Profitability (38%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.85% | N/A |
| ROE (TTM) | 14.11% | N/A |
| Net Profit Margin (TTM) | 12.95% | N/A |
| ROIC 5YR AVG | 1.54% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 103.17% | -7.32% | 29.58% |
| Revenue | 5.48% | 36.71% | 25.42% |
| Net Income | 104.11% | -5.73% | 37.10% |
| Cash Flow | -0.39% | 543.18% | 212.50% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.13 | N/A |
| Quick Ratio (TTM) | 1.13 | N/A |
| D/E Ratio (TTM) | 0.05 | N/A |
| Interest Coverage (TTM) | 91.75 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.60 | N/A |
| LTL to 5YR AVG FCF | 0.85 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.57% | N/A |